Familiar Renal Disease, Epidemiology and Genetics in Niteroi/Rio de Janeiro
NCT ID: NCT03114852
Last Updated: 2020-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1308 participants
OBSERVATIONAL
2017-03-20
2020-09-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
NCT07262320
Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy
NCT04225013
Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study
NCT05273424
Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap
NCT07103629
Chronic Kidney Disease: Determinants of Progression and Cardiovascular Risk
NCT03393663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CKD patients
'blood collection'
Patients with chronic kidney disease in renal replacement therapy living in the sanitary administrative region of Niteroi/Rio de Janeiro. They will be interviewed about past history of familiar renal disease. They will have blood functional renal biochemistry analysed.
blood collection
They will have blood tested to renal genetic diseases
Renal Familiar Disease
'blood collection' They will have blood tested to renal genetic diseases
blood collection
They will have blood tested to renal genetic diseases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood collection
They will have blood tested to renal genetic diseases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Relatives among the familial people of the index cases.
Exclusion Criteria
* Non-familial cases of known Glomerulonephritis
* Refuse in participating of interview and blood collection to genetic tests
12 Months
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal Fluminense
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jorge R Almeida, MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorge R Almeida, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal Fluminense
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal Fluminense
Niterói, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REGENT study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.